Didier Scherrer
Direttore Tecnico/Scientifico/R&S presso ABIVAX
Patrimonio netto: 564 574 $ in data 30/04/2024
Posizioni attive di Didier Scherrer
Società | Posizione | Inizio | Fine |
---|---|---|---|
ABIVAX | Direttore Tecnico/Scientifico/R&S | - | - |
Storia della carriera di Didier Scherrer
Precedenti posizioni note di Didier Scherrer
Società | Posizione | Inizio | Fine |
---|---|---|---|
LFB Biotechnologies SASU
LFB Biotechnologies SASU BiotechnologyHealth Technology LFB Biotechnologies SASU provides plasma-derived medicinal products. The firm undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The company was founded on September 21, 2006 and is headquartered in Courtaboeuf, France. | Direttore Tecnico/Scientifico/R&S | 01/06/2008 | 01/09/2009 |
AstraZeneca SAS
AstraZeneca SAS Pharmaceuticals: MajorHealth Technology AstraZeneca SAS researches, develops, produces, and commercializes pharmaceutical products. It offers solutions in different domains such as cardio-vascular, metabolism, oncology, respiratory, and inflammatory diseases. The company was founded on April 21, 1955 and is headquartered in Courbevoie, France. | Corporate Officer/Principal | 01/10/2005 | 01/06/2008 |
Entelos, Inc.
Entelos, Inc. Information Technology ServicesTechnology Services Entelos, Inc. develops predictive computer models of human disease. Its solutions include mechanism-based, mathematical models; virtual patients, populations; biosimulation software and biosimulation expertise. The company was founded in 1996 and is headquartered in San Mateo, CA. | Direttore Tecnico/Scientifico/R&S | 01/09/2000 | 01/09/2005 |
Splicos SAS
Splicos SAS Miscellaneous Commercial ServicesCommercial Services Splicos SAS provides therapeutic research and development services. The firm specializes in generating therapeutic leads and drug candidates for cancer, HIV, and genetic diseases. It offers technologies in the fields of alternative splicing and metastatic migration. The company was founded in 2008 and is headquartered in Montpellier, France. | Amministratore Delegato | 01/09/2009 | - |
Formazione di Didier Scherrer
Harvard Medical School | Doctorate Degree |
Stanford University School of Medicine | Doctorate Degree |
Louis Pasteur University | Doctorate Degree |
Statistiche
Distribuzione geografica
Francia | 6 |
Stati Uniti | 4 |
Posizioni
Doctorate Degree | 3 |
Chief Tech/Sci/R&D Officer | 3 |
Chief Executive Officer | 1 |
Settori
Consumer Services | 4 |
Health Technology | 4 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
ABIVAX | Health Technology |
Aziende private | 4 |
---|---|
Splicos SAS
Splicos SAS Miscellaneous Commercial ServicesCommercial Services Splicos SAS provides therapeutic research and development services. The firm specializes in generating therapeutic leads and drug candidates for cancer, HIV, and genetic diseases. It offers technologies in the fields of alternative splicing and metastatic migration. The company was founded in 2008 and is headquartered in Montpellier, France. | Commercial Services |
Entelos, Inc.
Entelos, Inc. Information Technology ServicesTechnology Services Entelos, Inc. develops predictive computer models of human disease. Its solutions include mechanism-based, mathematical models; virtual patients, populations; biosimulation software and biosimulation expertise. The company was founded in 1996 and is headquartered in San Mateo, CA. | Technology Services |
AstraZeneca SAS
AstraZeneca SAS Pharmaceuticals: MajorHealth Technology AstraZeneca SAS researches, develops, produces, and commercializes pharmaceutical products. It offers solutions in different domains such as cardio-vascular, metabolism, oncology, respiratory, and inflammatory diseases. The company was founded on April 21, 1955 and is headquartered in Courbevoie, France. | Health Technology |
LFB Biotechnologies SASU
LFB Biotechnologies SASU BiotechnologyHealth Technology LFB Biotechnologies SASU provides plasma-derived medicinal products. The firm undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The company was founded on September 21, 2006 and is headquartered in Courtaboeuf, France. | Health Technology |
- Borsa valori
- Insiders
- Didier Scherrer
- Esperienza